| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636967A Noval compounds, their use and preparation |
| 07/13/2005 | CN1636593A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1636563A 噻唑衍生物 Thiazole derivatives |
| 07/13/2005 | CN1210279C Thiazolo (4,5-D) pyrimidine compounds |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210270C Novel use of phenylheteroalkylamine derivatives |
| 07/13/2005 | CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916956 Calcium receptor antagonist |
| 07/12/2005 | US6916924 Reacting an aromatic or heteroaromatic carbamate with a heteroarylamine compound to form an intermediate, coupling the intermediate with an electrophile in suitable base and a catalyst |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916835 Nitrate esters and their use for neurological conditions |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005061471A1 Method of obtaining 2-mercaptobenzothiazole |
| 07/07/2005 | WO2005061470A1 1-akan-2-ol substituted piperazine and piperidine compounds |
| 07/07/2005 | WO2005061469A1 Method for producing chiral mercapto amino acids |
| 07/07/2005 | WO2005061465A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors |
| 07/07/2005 | WO2005061464A1 Herbicidal heteroaroyl-substituted phenylalanine amides |
| 07/07/2005 | WO2005061459A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | WO2005061458A2 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 07/07/2005 | WO2005061450A2 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | WO2005060958A1 (5- (2-phenyl)-thiazol-5-ylmethoxy)-indol-1-yl) -acetic acid derivatives and related compounds as modulators of the human ppar-delta receptor for the treatment of metabolic disorders such as type 2 diabetes |
| 07/07/2005 | WO2005060456A2 Method for treating adamts-5-associate disease |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2005037839A8 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 07/07/2005 | US20050148641 2-Methylthiazolidine-2,4-dicarboxylic acid and salts thereof for the treatment of neurodegenerative diseases |
| 07/07/2005 | US20050148623 HIV protease inhibiting compounds |
| 07/07/2005 | US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs |
| 07/07/2005 | US20050148588 LFA-1 antagonist compounds |
| 07/07/2005 | US20050148548 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
| 07/07/2005 | CA2792483A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2550257A1 1-akan-2-ol substituted piperazine and piperidine compounds |
| 07/07/2005 | CA2549389A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2548824A1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2548513A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | CA2548354A1 Herbicidal heteroaroyl-substituted phenylalanine amides |
| 07/07/2005 | CA2547879A1 Method of obtaining 2-mercaptobenzothiazole |
| 07/07/2005 | CA2547617A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 07/07/2005 | CA2547575A1 Method for treating adamts-5-associated disease |
| 07/06/2005 | EP1550655A1 Bicyclic intermediates |
| 07/06/2005 | EP1549644A1 Azolidinone-vinyl fused-benzene derivatives |
| 07/06/2005 | EP1549626A1 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
| 07/06/2005 | EP1549625A1 Novel heterocyclic analogs of diphenylethylene compounds |
| 07/06/2005 | EP1549624A2 Inhibitors of fatty acid amide hydrolase |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1549283A1 Merocyanine derivatives for cosmetic use |
| 07/06/2005 | EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 07/06/2005 | CN1635888A 2-methylthiazolidine-2, 4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases |
| 07/06/2005 | CN1634900A Method for preparing 3-methyl-2-benzothiazolinone hydrazone and its hydrochloride |
| 07/06/2005 | CN1209362C Tetrazolyl-phenyl acetamide glucokinase activators |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914079 Antiproliferative agents; anticancer agents |
| 07/05/2005 | US6914062 Pyrazinone derivatives |
| 06/30/2005 | WO2005058887A1 Novel thiazole derivates |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058849A1 New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them |
| 06/30/2005 | WO2005058840A2 Method of coloring with capped diazotized compound and coupling component |
| 06/30/2005 | WO2005058810A1 Novel intermediates for the synthesis of (r)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2005000852A3 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 06/30/2005 | WO2004085388A3 Cyclic protein tyrosine kinase inhibitors |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143581 Process for preparation of alkoxybenzamides and thiazolyl isocyanates |
| 06/30/2005 | US20050143429 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 06/30/2005 | US20050143428 plant-fortifying (resistance-inducing) substances; used for mobilizing the defences of the plant against attack by unwanted microorganisms |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050143418 Pesticidal heterocycles |
| 06/30/2005 | US20050143366 Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders |
| 06/30/2005 | US20050143316 Hepatitis C virus inhibitors |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | CA2550012A1 Urea derivative, process for producing the same and use |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2547804A1 Novel thiazole derivatives |
| 06/29/2005 | EP1548013A1 Process for producing optically active alpha-substituted cysteine or salt thereof, intermediate therefor, and process for producing the same |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1546124A1 Process for preparing substituted phenoxy-acetic acids from phenols |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1545532A2 Heterocyclic compounds |
| 06/29/2005 | EP1545518A1 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors |
| 06/29/2005 | EP1545517A1 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma |
| 06/29/2005 | CN1633426A 1, 3-dihydroxy benzene derivatives and coloring agent containing the same |
| 06/29/2005 | CN1633421A Oxazole/thiazol-derivatives activators of the hppar-alpha receptor |
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1633293A 5-ht2b receptor antagonists |
| 06/29/2005 | CN1633289A Hemiasterlin derivatives and uses thereof |
| 06/29/2005 | CN1631144A Biocidal composition and its use |
| 06/29/2005 | CN1208685C Photosensitive compound and photoresist |
| 06/29/2005 | CN1208327C Process for preparing S, Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound |